Document is current

Article History

Received: 23 April 2022

Accepted: 8 September 2022

First Online: 22 September 2022

Competing interests

: Jorge Toledano-Serrabona, Leire Díez-Tercero and Begoña M. Bosch Bosch have received no grants, personal fees or non-financial support. F. Javier Gil reports grants from Ministry of Science and Innovation of Spain, during the conduct of the study. F. Javier Gil personal fees, and non-financial support from Klockner Dental Implants (Barcelona, Spain), outside the submitted work. Octavi Camps-Font reports grants from Instituto de Salud Carlos III during the conduct of the study. Octavi Camps-Font reports grants, personal fees and non-financial support from Avinent (Santpedor, Spain), outside the submitted work. Camps-Font has participated as co-investigator in clinical trials sponsored by Mundipharma (Cambridge, UK) and Menarini Richerche (Florence, Italy). Eduard Valmaseda-Castellón reports grants from Instituto de Salud Carlos III during the conduct of the study. Eduard Valmaseda-Castellón reports personal fees and non-financial support from MozoGrau (Valladolid, Spain). He has received personal fees from BioHorizons Ibérica (Madrid, Spain), Inibsa Dental (Lliça de Vall, Spain) and Dentsply implants Iberia (Barcelona, Spain) outside the submitted work. Valmaseda-Castellón is the Director of the Avinent-University of Barcelona research agreement (Càtedra UB-Avinent). In addition, Valmaseda-Castellón has participated as an investigator in clinical trials sponsored by Mundipharma (Cambridge, UK) and Geistlich (Wolhusen, Switzerland), outside the submitted work. Cosme Gay-Escoda reports grants from Instituto de Salud Carlos III during the conduct of the study. Cosme Gay-Escoda reports grants, personal fees, and non-financial support from Mundipharma (Cambridge, UK) and Menarini Richerche (Florence, Italy), outside the submitted work, outside the submitted work. Mª Ángeles Sánchez-Garcés reports grants from Instituto de Salud Carlos III during the conduct of the study. Mª Ángeles Sánchez-Garcés reports personal fees from Nobel Biocare (Göteborg, Sweden), Zimmer Biomet (Warsaw, USA) and Menarini Richerche (Florence, Italy), outside the submitted work.